BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 14517428)

  • 1. Role of endothelial cell survival and death signals in angiogenesis.
    Nör JE; Polverini PJ
    Angiogenesis; 1999; 3(2):101-16. PubMed ID: 14517428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of endothelial cell survival by an inhibitor of angiogenesis thrombospondin-1: a dynamic balance.
    Volpert OV
    Cancer Metastasis Rev; 2000; 19(1-2):87-92. PubMed ID: 11191069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.
    Battegay EJ
    J Mol Med (Berl); 1995 Jul; 73(7):333-46. PubMed ID: 8520966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of endothelial cell survival and apoptosis during angiogenesis.
    Chavakis E; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):887-93. PubMed ID: 12067894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of vessel regression: toward an understanding of the resolution of angiogenesis.
    Wietecha MS; Cerny WL; DiPietro LA
    Curr Top Microbiol Immunol; 2013; 367():3-32. PubMed ID: 23224648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors.
    Verheul HM; Pinedo HM
    Clin Breast Cancer; 2000 Sep; 1 Suppl 1():S80-4. PubMed ID: 11970755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis: regulators and clinical applications.
    Liekens S; De Clercq E; Neyts J
    Biochem Pharmacol; 2001 Feb; 61(3):253-70. PubMed ID: 11172729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathophysiology of angiogenesis.
    Polverini PJ
    Crit Rev Oral Biol Med; 1995; 6(3):230-47. PubMed ID: 8785263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Venous Endothelial Cells in Developmental and Pathologic Angiogenesis.
    Lee HW; Xu Y; He L; Choi W; Gonzalez D; Jin SW; Simons M
    Circulation; 2021 Oct; 144(16):1308-1322. PubMed ID: 34474596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of vascular endothelial junction stability and remodeling through Rap1-Rasip1 signaling.
    Wilson CW; Ye W
    Cell Adh Migr; 2014; 8(2):76-83. PubMed ID: 24622510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies.
    Dai C; Webster KA; Bhatt A; Tian H; Su G; Li W
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and angiogenesis: two promising tumor markers in breast cancer (review).
    Wu J
    Anticancer Res; 1996; 16(4B):2233-9. PubMed ID: 8694549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.
    Tal R; Segars JH
    Hum Reprod Update; 2014; 20(2):194-216. PubMed ID: 24077979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
    Rüegg C; Dormond O; Mariotti A
    Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing Vessel Regression and Endothelial Apoptosis as a Component of Angiogenic Vessel Remodeling.
    Whitehead L; Watson EC; Grant ZL
    Methods Mol Biol; 2022; 2441():29-39. PubMed ID: 35099726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of miR-133a in endothelial cells inhibits angiogenesis by reducing pro-angiogenic but increasing anti-angiogenic gene expression.
    Ahmed S; Kurusamy S; David ELS; Khan K; Kalyanakrishnan K; Ian-Gobo M; Kola TM; Wilkinson RN; Kannappan V; Wang W; Gómez MJ; Redondo JM; Cotton J; Armesilla AL
    Sci Rep; 2022 Aug; 12(1):14730. PubMed ID: 36042288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6'-Sialylgalactose inhibits vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Chung TW; Kim EY; Choi HJ; Han CW; Jang SB; Kim KJ; Jin L; Koh YJ; Ha KT
    Exp Mol Med; 2019 Oct; 51(10):1-13. PubMed ID: 31604908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.